Castleman Disease - 59 Studies Found
Completed |
: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease :
|
Completed |
: Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease : Multiple Myeloma and Plasma Cell Neoplasm : 1999-11-01 : Drug: suramin |
Completed |
: Dose-escalation Study of Oral CX-4945 :
|
Recruiting |
: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity :
: |
Recruiting |
: Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer :
: 2014-03-04 : Drug: Nelfinavir Nelfinavir will be given 3000 mg orally twice daily on days 1-14 of a 14-day cycle. NFV |
Terminated |
: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection :
|
Recruiting |
: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma : Kaposi Sarcoma : 2016-01-20 :
|
Completed |
: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis :
: Drug: tanespimycin |